Arcaea

Arcaea is owned by Ginkgo BioWorks.

Ginkgo BioWorks is one of the...

• Russell 3000.

Ginkgo BioWorks is a company listed under the stock ticker DNA (US).

They are in:

• Biotechnology50%
• Healthcare50%

Acquisition, funding and merger involving Ginkgo BioWorks.

• Ginkgo BioWorks has announced the acquisition of Zymergen  (posted on July 27 2022).

View the org chart displaying its 10 main executives

Most searched biographies at Arcaea

• Jasmina Aganovic, Chief Executive Officer
• Jennifer Cookson, Senior Director of Development
• Jenny Heim, Vice President of Supply Chain Operations

Create your alert
to follow the executive moves at Arcaea.

Ginkgo BioWorks has 1,830 competitors including IQVIA (United States (USA)), Siemens Healthineers (Germany) and Saint Francis Health System (United States (USA)).

Popular M&A news in Healthcare

• SmarterDx has just announced a $50 Million fundraising (posted on May 16 2024).
• KKR has announced the acquisition of Healthium  (posted on May 9 2024).
• Rad AI has just announced a $50 Million fundraising (posted on May 7 2024).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Paulo Junqueira Moll - Chief Executive Officer at Rede D'Or Sao Luiz
• Ralph De La Torre - Chairman and Chief Executive Officer at Steward Health Care

Learn more about the Healthcare industry >

Press releases by Arcaea

• Arcaea Launches Fragrances That Smell Like Extinct Flowers

Social media about Arcaea

• Arcaea on Wikipedia, Google News & Yahoo Finance
• Arcaea on LinkedIn, Twitter & YouTube

Contact by email its executives including Jasmina Aganovic

Call Arcaea at +1 877...

View the org chart

Register to receive your alert

Report an error